Cologne, Germany

Hanna Plittersdorf




Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Köln, DE (2013)
  • Cologne, DE (2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Journey of Hanna Plittersdorf: A Leader in Biomedicine

Introduction: Hanna Plittersdorf, an accomplished inventor based in Cologne, Germany, has made significant contributions to the field of biomedicine through her innovative work. With two patents to her name, her research primarily focuses on antibodies that target tumor necrosis factor alpha (TNFα), a crucial element in various inflammatory diseases.

Latest Patents: Hanna's latest patents feature advancements in antibodies capable of binding TNFα. These patents detail the antibodies, antigen binding portions, and derivatives that show potential in treating conditions linked to inflammation. Furthermore, the patents include nucleic acids encoding these antibodies, along with complementary nucleic acids, vectors, and host cells that house these innovations. These developments are promising for therapeutic applications and emphasize Hanna's expertise in antibody technology.

Career Highlights: Throughout her impressive career, Hanna Plittersdorf has contributed her knowledge and skills to renowned institutions such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. Her work at these companies has played a vital role in advancing medical research and commercialization of innovative treatments.

Collaborations: Collaboration is key in the field of invention, and Hanna has worked alongside notable colleagues, including Christian Votsmeier and Uwe Gritzan. These partnerships have fostered a dynamic environment for innovative thinking and have propelled significant advancements in their shared areas of expertise.

Conclusion: Hanna Plittersdorf's achievements in biomedicine and her commitment to developing innovative therapies stand as a testament to her role as an influential inventor. Her contributions not only advance scientific knowledge but also open new pathways for the treatment of diseases through targeted therapies. As the field of biomedicine continues to evolve, Hanna’s work will likely inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…